VERASTEM ($VSTM) posted quarterly earnings results on Tuesday, November 4th. The company reported earnings of -$1.35 per share, missing estimates of -$0.65 by $0.70. The company also reported revenue of $11,240,000, beating estimates of $5,772,628 by $5,467,372.
You can see Quiver Quantitative's $VSTM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
VERASTEM Insider Trading Activity
VERASTEM insiders have traded $VSTM stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $VSTM stock by insiders over the last 6 months:
- DAN PATERSON (President and CEO) has made 0 purchases and 5 sales selling 78,542 shares for an estimated $581,926.
- DANIEL CALKINS (Chief Financial Officer) has made 0 purchases and 5 sales selling 15,360 shares for an estimated $112,542.
- PAUL A. BUNN sold 8,333 shares for an estimated $75,496
- BRIAN M STUGLIK has made 0 purchases and 2 sales selling 1,181 shares for an estimated $9,220.
- ROBERT E. GAGNON has made 0 purchases and 2 sales selling 565 shares for an estimated $4,411.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
VERASTEM Hedge Fund Activity
We have seen 72 institutional investors add shares of VERASTEM stock to their portfolio, and 41 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORBIMED ADVISORS LLC removed 2,862,448 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $11,879,159
- J. GOLDMAN & CO LP added 2,277,282 shares (+1284.9%) to their portfolio in Q2 2025, for an estimated $9,450,720
- ARMISTICE CAPITAL, LLC added 2,136,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $8,864,400
- AIGH CAPITAL MANAGEMENT LLC removed 2,003,179 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $17,688,070
- MARSHALL WACE, LLP removed 1,957,261 shares (-87.9%) from their portfolio in Q2 2025, for an estimated $8,122,633
- STATE STREET CORP added 1,439,274 shares (+177.2%) to their portfolio in Q2 2025, for an estimated $5,972,987
- BVF INC/IL added 1,303,957 shares (+62.1%) to their portfolio in Q2 2025, for an estimated $5,411,421
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
VERASTEM Analyst Ratings
Wall Street analysts have issued reports on $VSTM in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 10/16/2025
- BTIG issued a "Buy" rating on 09/09/2025
- RBC Capital issued a "Outperform" rating on 08/08/2025
- HC Wainwright & Co. issued a "Buy" rating on 05/09/2025
To track analyst ratings and price targets for VERASTEM, check out Quiver Quantitative's $VSTM forecast page.
VERASTEM Price Targets
Multiple analysts have issued price targets for $VSTM recently. We have seen 3 analysts offer price targets for $VSTM in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- Justin Zelin from BTIG set a target price of $20.0 on 09/09/2025
- Leonid Timashev from RBC Capital set a target price of $13.0 on 08/08/2025
- Sean Lee from HC Wainwright & Co. set a target price of $14.0 on 05/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.